Showing results (331-340 of 491) with videos related to
Sort By:
Pageof 50
Blood|June 1, 1995
9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemiaW H Miller, A Jakubowski, W P Tong, et al.Journal of the American College of Cardiology|June 16, 2012
Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trialMatthew J Price, James S Walder, Brian A Baker, et al.Clinical Pharmacology and Therapeutics|March 16, 2007
Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differentlyN A Farid, C D Payne, D S Small, et al.Journal of the American College of Cardiology|September 18, 2010
Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet) studyDominick J Angiolillo, Jorge F Saucedo, Roger Deraad, et al.Thrombosis Research|December 26, 2013
A phase 1 study of prasugrel in patients with sickle cell disease: effects on biomarkers of platelet activation and coagulationJoseph A Jakubowski, Chunmei Zhou, Stipo Jurcevic, et al.Journal of Cardiovascular Pharmacology|April 7, 2007
Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjectsJoseph A Jakubowski, Christopher D Payne, Govinda J Weerakkody, et al.Journal of Cardiovascular Pharmacology|April 25, 2006
The platelet inhibitory effects and pharmacokinetics of prasugrel after administration of loading and maintenance doses in healthy subjectsJoseph A Jakubowski, Christopher D Payne, John T Brandt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemiaS L Soignet, S R Frankel, D Douer, et al.British Journal of Clinical Pharmacology|November 23, 2012
A phase 1 study of prasugrel in patients with sickle cell disease: pharmacokinetics and effects on ex vivo platelet reactivityJoseph A Jakubowski, Chunmei Zhou, David S Small, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 3, 2017
Co-Infections by Double-Stranded DNA Viruses after Ex Vivo T Cell-Depleted, CD34+ Selected Hematopoietic Cell TransplantationYao-Ting Huang, Seong Jin Kim, Yeon Joo Lee, et al.Pageof 50